United States Breast Cancer Screening Market Forecast (Mammography, MRI & Ultrasound)
United States Breast Cancer Screening Market is expected to reach more than US$ 5.8 Billion by 2022. Long–term Growth Projection: • Mammography grasp the dominant share in the United States Breast Cancer Screening Market • Breast MRI Screening market is likely to reach more than US$ 350 Million by 2022 • Number of mammograpy screening population in United States will increase to more than 50 Million by 2022 Market growth can be attributed to factors such as increasing incidence of breast cancer, increasing awareness related to early breast cancer detection, growing government investments and funding for breast cancer screening, technological advancement in breast imaging technologies and implementation of several initiatives to create awareness about the early detection of breast cancer. “United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022” provides a deep and thorough evaluation of the United States Breast Cancer Screening Market. The report provides an in–depth analysis of the breast cancer invasive, in situ and men cases and added breast cancer death figures of both men and women in United States. Furthermore, the report also covered mammography screening population from 2010 to 2022. Market outlook in value terms has been analyzed based on historical, current and potential trends and the market is projected from 2017 to 2022. The breast cancer screening market is segmented based on its product types: Mammography, Breast MRI and Breast Ultrasound. Additionally, the report includes assessment of clinical trials and reimbursement pattern. The report also explores detailed description of growth drivers and inhibitors of the United States Breast Cancer Screening Market.
98 views • 5 slides
